|  |
Public Act 104-0252
Public Act 0252 104TH GENERAL ASSEMBLY | Public Act 104-0252 | | HB2874 Enrolled | LRB104 09796 RLC 19862 b |
|
| AN ACT concerning criminal law. | Be it enacted by the People of the State of Illinois, | represented in the General Assembly: | Section 5. The Illinois Controlled Substances Act is | amended by changing Section 216 as follows: | (720 ILCS 570/216) | Sec. 216. Ephedrine. | (a) The following drug products containing ephedrine, its | salts, optical isomers and salts of optical isomers shall be | exempt from the application of Sections 312 and 313 of this Act | if they: (i) may lawfully be sold over-the-counter without a | prescription under the Federal Food, Drug, and Cosmetic Act; | (ii) are labeled and marketed in a manner consistent with | Section 341.76 of Title 21 of the Code of Federal Regulations; | (iii) are manufactured and distributed for legitimate | medicinal use in a manner that reduces or eliminates the | likelihood of abuse; and (iv) are not marketed, advertised, or | labeled for the indications of stimulation, mental alertness, | weight loss, muscle enhancement, appetite control, or energy: | (1) Solid oral dosage forms, including soft gelatin | caplets, which are formulated pursuant to 21 CFR 341 or | its successor, and packaged in blister packs of not more | than 2 tablets per blister. |
| (2) Anorectal preparations containing not more than 5% | ephedrine. | (b) The marketing, advertising, or labeling of any product | containing ephedrine, a salt of ephedrine, an optical isomer | of ephedrine, or a salt of an optical isomer of ephedrine, for | the indications of stimulation, mental alertness, weight loss, | appetite control, or energy, is prohibited. In determining | compliance with this requirement the Department may consider | the following factors: | (1) The packaging of the drug product; | (2) The name and labeling of the product; | (3) The manner of distribution, advertising, and | promotion of the product; | (4) Verbal representations made concerning the | product; | (5) The duration, scope, and significance of misuse of | the particular product. | (c) A violation of this Section is a Class A misdemeanor. A | second or subsequent violation of this Section is a Class 4 | felony. | (d) This Section does not apply to dietary supplements, | herbs, or other natural products, including concentrates or | extracts, which: | (1) are not otherwise prohibited by law; and | (2) may contain naturally occurring ephedrine, | ephedrine alkaloids, or pseudoephedrine, or their salts, |
| isomers, or salts of isomers, or a combination of these | substances, that: | (i) are contained in a matrix of organic material; | and | (ii) do not exceed 15% of the total weight of the | natural product. | (e) Nothing in this Section limits the scope or terms of | the Methamphetamine Precursor Control Act. | (f) This Section does not apply to the sale of any product | dispensed or delivered by a practitioner or pharmacy according | to a prescription issued by a prescriber authorized by this | State or another state for a valid medical purpose and in the | course of professional practice. | (Source: P.A. 103-881, eff. 1-1-25.) |
Effective Date: 1/1/2026
|
|
|
|